General Practice Doctors in Huntsville, AL Accepting Medicare

7 General Practice doctors found. Showing 1 - 7

Dr. Mary Barbara Sullivan, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1403 Wind River Dr Se, Huntsville, AL 35802 Phone: 256-883-7286

Taurin Pyongkap Lee, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2713 Downing St, Huntsville, AL 35801 Phone: 256-883-5752    Fax: 256-883-5752

Dr. Hayley Michelle Garner Degraaff, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 115 Queensbury Dr Sw, Huntsville, AL 35802 Phone: 256-882-6555    Fax: 256-882-2844

Dr. Ernest Sheppard Campbell, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 717 Pratt Ave Ne, Huntsville, AL 35801 Phone: 256-886-0989

Ms. Jennifer Sheridan, FNP-C General Practice Medicare: Not Enrolled in Medicare Practice Location: 2139 Winchester Rd Ne, Huntsville, AL 35811 Phone: 256-489-9015

Alicea M Mingo, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1405 Wind River Dr Se, Huntsville, AL 35802 Phone: 360-440-3410

Julie Marie Mckibben, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4810 Whitesport Cir Sw, Suite 215, Huntsville, AL 35801 Phone: 256-429-4540    Fax: 256-429-4546

News Archive

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Mayo Clinic Cancer Center investigators report that combination therapy with lenalidomide (Revlimid) and dexamethasone (combination is called Rev/Dex) looks like a breakthrough treatment for multiple myeloma. Results of a Phase II clinical trial were published online Aug. 23 in Blood.

New data shows Valortim antibody enhances human T cell response to B. anthracis

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that new data from the Company's Valortim® anthrax anti-toxin program were presented at the 8th Annual ASM Biodefense and Emerging Diseases Research Meeting, held in Baltimore, Maryland, February 21-24, 2010.

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online by Expert Opinion on Pharmacotherapy. In addition, this study compared oxycodone controlled-release (CR) to placebo as an active control.

Accenture Innovation Center for Health launched to tackle challenges facing the global health industry

Accenture (NYSE: ACN) today launched the Accenture Innovation Center for Health in response to the growing global demand for insights into and strategies to confront the top health issues and challenges affecting citizens worldwide. The center serves as the focal point for Accenture's thought capital and proven assets for tackling the most pressing challenges facing the global health industry.

Public opinion has changed since Clinton tried health care reform

Public opinions have changed since President Bill Clinton tried to reform the health care system more than a a decade ago. USA Today reports that "the years since Clinton's failed effort have seen the cost of medical services nearly double and softened some of the skepticism voiced by Americans in 1993 and 1994. The percentage who say Congress should pass comprehensive legislation, rather than dealing with health care incrementally over several years, has increased by 10 points, USA TODAY/Gallup Polls show."

Read more Medical News

› Verified 9 days ago